Automated insulin delivery was improved with improved glycemic control metrics among patients with type 2 diabetes regardless of C-peptide levels.
USA: A new study published in Diabetes Care revealed that automated insulin delivery (AID) systems lowered A1C levels and ...
A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for ...
As earlier studies have suggested an abnormal neuro-humoral control of the endocrine pancreas in obesity, we have investigated 11 obese school girls (89.3kg ± 15.2, mean ±SD) and 9 agematched controls ...
Hosted on MSN
What Is the C-Peptide Test for Diabetes?
What Is C-Peptide? Why It’s Done How It’s Performed What’s Next The C-peptide test is a way of estimating how much of the hormone insulin your body creates. This test can help doctors determine what ...
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels This sub-analysis is the first study to evaluate ...
The new findings come from a 15-year study examining the natural course of C-peptide in children and adolescents with type 1 diabetes (T1D). A marker of pancreatic function in patients with diabetes ...
Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on each patient’s clinical condition when determining initial treatment, ...
Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831 This is an ASCO Meeting Abstract from the 2006 ...
Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results